Gwénaël Le Teuff

11PUBLICATIONS
152CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Stochastic analysis and modellingPredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

|Sep 23, 2025
Transcriptomic biomarkers related to cardiac disease in childhood cancer survivors: a case-control study.

Naïla Aba, Gwénaël Le Teuff, Brice Fresneau

|Sep 21, 2025
Bayesian generalized method of moments applied to pseudo-observations in survival analysis.

Léa Orsini, Caroline Brard, Emmanuel Lesaffre

|Aug 21, 2024
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial.

Karim Fizazi, Gwénaël Le Teuff, Aude Fléchon

Pageof 2